Eczema Sleep Study
Many patients with atopic dermatitis (AD, also known as eczema), especially if it is moderate to severe AD, have problems sleeping due to itching, scratching or skin pain. However, not enough data/evidence is available to know how sleep disturbance may change with AD treatment. We are looking for eligible candidates to volunteer for a study to collect data/evidence from patients like you who will be treated with dupilumab to evaluate whether or not dupilumab helps to improve sleep quality in AD patients.
To qualify you must be:
- 18yo and older
- diagnosed by a physician at least 3 years ago
- At least 10% of body covered in eczema
- Itching from eczema is keeping you awake
- This an FDA approved medication.
- No blood draws.
- Qualified recipients may receive compensation for your time.
If you are interested in participating in this study being conducted, please fill out the form below. If you are a qualified candidate, a representative from our research department will be in touch with you.
Your information will be used for the sole purpose of qualifying you for this study. We will not, in any circumstances, share your personal information with other individuals or organizations without your permission.